Search - tctmd.com

Displaying 801 - 820 of 3520

Sort: Relevancy | Date

Presentation TCT 2023

Update on Current Treatment Targets for Secondary Prevention

Presenter: Dominick Angiolillo

October 26, 2023

Presentation TCT 2023

Secondary Prevention Needs to Be Addressed in the Cath Lab!

Presenter: Ajay Kirtane

October 26, 2023

Presentation TCT 2023

TCT 973: STENT LOSS AND AVULSION DURING PCI OF OSTIAL LAD.

Presenter: Andrea Mignatti

October 26, 2023

Presentation TCT 2023

Case Setup: Complex Elective PCI

Presenter: Yousif Ahmad

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2023

Debate – Most PCI Operators Should Not Be Performing Renal Denervation (Con)

Presenter: Dmitriy Feldman

October 25, 2023

Presentation TCT 2023

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

Presenter: Andrew Sharp

October 25, 2023

Presentation TCT 2023

TCT 770: Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry

Presenter: Aleksandra Gasecka

October 25, 2023

Presentation TCT 2023

TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

Presenter: Imran Shah

October 25, 2023

Presentation TCT 2023

TCT 433: Clinical and Procedural Outcomes of Percutaneous Coronary Intervention for De Novo Lesions involving the Ostial Left Circumflex Coronary Artery

Presenter: Ottavia Cozzi

October 25, 2023

Presentation TCT 2023

TCT 505: CKD Risk Stratification Within a Cohort of Patients Undergoing Ultralow-contrast IVUS-Guided PCI

Presenter: Christopher Garnett

October 25, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 461: Suboptimal Lipid Lowering Treatment After Complex PCI in Contemporary Practice

Presenter: Denise Peeters

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

Presenter: Mick Renkens

October 25, 2023

Presentation TCT 2023

TCT 800: Is there a good time to deal with massive Left Main bifurcation calcium nodule? Case of restenosis after primary PCI of calcified lesion sucesfully trated with intravascular lithotrypsy and provissional stenting

Presenter: Piotr Pawluczuk

October 25, 2023

Presentation TCT 2023

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

Presenter: Hyun Jin Ahn

October 25, 2023

Presentation TCT 2023

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

Presenter: Georg Nollert

October 25, 2023

Presentation TCT 2023

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

Presenter: Jung-Hee Lee

October 25, 2023

Presentation TCT 2023

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

Presenter: Jared Romeo

October 25, 2023

Advertisement

Update on Current Treatment Targets for Secondary Prevention

Secondary Prevention Needs to Be Addressed in the Cath Lab!

TCT 973: STENT LOSS AND AVULSION DURING PCI OF OSTIAL LAD.

Case Setup: Complex Elective PCI

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Debate – Most PCI Operators Should Not Be Performing Renal Denervation (Con)

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

TCT 770: Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry

TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

TCT 433: Clinical and Procedural Outcomes of Percutaneous Coronary Intervention for De Novo Lesions involving the Ostial Left Circumflex Coronary Artery

TCT 505: CKD Risk Stratification Within a Cohort of Patients Undergoing Ultralow-contrast IVUS-Guided PCI

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 461: Suboptimal Lipid Lowering Treatment After Complex PCI in Contemporary Practice

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

TCT 800: Is there a good time to deal with massive Left Main bifurcation calcium nodule? Case of restenosis after primary PCI of calcified lesion sucesfully trated with intravascular lithotrypsy and provissional stenting

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content